Internal Medicine, Endocrinology, Diabetes, & Metabolism · Staten Island, NY
NPI
1962581066
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
1050 Clove Road
Staten Island, NY, 10301
Phone (718) 816-6440
Groups this clinician bills Medicare through
Medicare paid, 2024
$68K
694 services
Medicare patients, 2024
298
Average age 70
Drug cost, 2024
$2.8M
6,484 prescriptions
Company payments, 2024
$38.4
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fiby E Hanna was code 99214 (office e&m - established), 567 times for 274 patients. In total Fiby E Hanna billed 694 services in 7 codes, and Medicare paid $68K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 567 | 274 | $102.58 | $58K |
| 83036 Blood Count | Office | 41 | 36 | $9.52 | $390 |
| 99204 Office E&M - New | Office | 32 | 32 | $128.77 | $4,121 |
| 10005 Other Organ Systems | Office | 26 | 25 | $122.03 | $3,173 |
| 99203 Office E&M - New | Office | 21 | 21 | $96.40 | $2,024 |
By year: 2022 $77K for 826 services; 2023 $76K for 784 services; 2024 $68K for 694 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 41 | 36 | $9.52 | $390 |
Medicare prescription drug claims, 2024
In 2024, the drug Fiby E Hanna prescribed most often to Medicare patients was Levothyroxine Sodium, with 736 prescriptions and refills. In total Fiby E Hanna wrote 6,484 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 736 | 1,887 | 221 | $8,536 |
| Ozempic Semaglutide | 434 | 772 | 101 | $736K |
| Metformin Hcl Generic | 409 | 1,000 | 135 | $3,146 |
| Glipizide Generic | 403 | 900 | 111 | $5,992 |
| Mounjaro Tirzepatide | 288 | 399 | 63 | $404K |
| Synthroid Levothyroxine Sodium | 262 | 745 | 82 | $26K |
| Janumet Xr Sitagliptin Phos/Metformin Hcl | 256 | 530 | 71 | $273K |
| Rosuvastatin Calcium Generic | 248 | 638 | 83 | $3,990 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 209 | 412 | 51 | $224K |
| Repaglinide Generic | 194 | 484 | 66 | $4,442 |
| Atorvastatin Calcium Generic | 182 | 479 | 68 | $1,768 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 160 | 260 | 40 | $19K |
| Jardiance Empagliflozin | 143 | 330 | 44 | $189K |
| Metformin Hcl Er Metformin Hcl | 143 | 311 | 39 | $2,740 |
| Methimazole Generic | 133 | 349 | 41 | $1,590 |
Brand drugs: 2,991 claims; generic drugs: 3,029 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Fiby E Hanna $38.4 ($38.4 in general payments such as food, travel and fees) from 1 company. The largest payer was Xeris Pharmaceuticals, Inc. with $38.4.
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 2 | $38.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.